Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report

BACKGROUND: Immune checkpoint inhibitors targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed death-1 receptor (PD-1), and programmed death-1 receptor and its ligand (PD-L1) increased the survival of patients affected by metastatic malignant melanoma. Due to their mechanism of...

Descripción completa

Detalles Bibliográficos
Autores principales: Siciliano, Maria Anna, Dastoli, Stefano, d’Apolito, Maria, Staropoli, Nicoletta, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Barbieri, Vito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591674/
https://www.ncbi.nlm.nih.gov/pubmed/33163407
http://dx.doi.org/10.3389/fonc.2020.579445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591674/
https://www.ncbi.nlm.nih.gov/pubmed/33163407
http://dx.doi.org/10.3389/fonc.2020.579445

Ejemplares similares